Mayne Pharma Group Ltd. (MAYNF)

1.40 -0.31 (-18.07%) USD  |  OTCM  |  May 20, 12:37
More

Mayne Pharma Group EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for MAYNF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Starpharma Holdings Ltd. Upgrade
Percheron Therapeutics Ltd. Upgrade
Neuren Pharmaceuticals Ltd. Upgrade
Acrux Ltd. Upgrade
Invion Ltd. Upgrade